Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi


10.1073/pnas.1419162112

http://scihub22266oqcxt.onion/10.1073/pnas.1419162112
suck pdf from google scholar
C4418889!4418889 !25870266
unlimited free pdf from europmc25870266
    free
PDF from PMC    free
html from PMC    free

suck abstract from ncbi


Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\25870266 .jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117
pmid25870266
      Proc+Natl+Acad+Sci+U+S+A 2015 ; 112 (17 ): 5467-72
Nephropedia Template TP

gab.com Text

Twit Text FOAVip

Twit Text #

English Wikipedia


  • Post-treatment control of HIV infection #MMPMID25870266
  • Conway JM ; Perelson AS
  • Proc Natl Acad Sci U S A 2015[Apr]; 112 (17 ): 5467-72 PMID25870266 show ga
  • Antiretroviral therapy (ART) for HIV is not a cure. However, recent studies suggest that ART, initiated early during primary infection, may induce post-treatment control (PTC) of HIV infection with HIV RNA maintained at <50 copies per mL. We investigate the hypothesis that ART initiated early during primary infection permits PTC by limiting the size of the latent reservoir, which, if small enough at treatment termination, may allow the adaptive immune response to prevent viral rebound (VR) and control infection. We use a mathematical model of within host HIV dynamics to capture interactions among target cells, productively infected cells, latently infected cells, virus, and cytotoxic T lymphocytes (CTLs). Analysis of our model reveals a range in CTL response strengths where a patient may show either VR or PTC, depending on the size of the latent reservoir at treatment termination. Below this range, patients will always rebound, whereas above this range, patients are predicted to behave like elite controllers. Using data on latent reservoir sizes in patients treated during primary infection, we also predict population-level VR times for noncontrollers consistent with observations.
  • |*Adaptive Immunity [MESH]
  • |*HIV Infections/immunology/prevention & control [MESH]
  • |*Models, Immunological [MESH]
  • |CD8-Positive T-Lymphocytes/*immunology [MESH]
  • |Female [MESH]
  • |HIV-1/*physiology [MESH]
  • |Humans [MESH]


  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    Linkout box